The Impact of Emicizumab Prophylaxis on Hospitalizations and Emergency Department Visits Among Hemophilia A Patients Is Age Related
This real-world analysis demonstrates a substantial decrease in ED visits and hospitalizations, following emicizumab prophylaxis in HA patients. However, this improvement was age dependent as it was observed only among children. Further prospective studies evaluating this aspect may shed light on these findings.
Authors
- Shadan Lalezari (ORCID: https://orcid.org/0000-0002-6112-1127)
- Ivan Budnik (ORCID: https://orcid.org/0000-0002-6652-2667)
- Aharon Lubetsky
- Tami Brutman‐Barazani (ORCID: https://orcid.org/0009-0009-8651-2501)
- Orly Efros (ORCID: https://orcid.org/0000-0002-6024-9110)
- Sarina Levy‐Mendelovich (ORCID: https://orcid.org/0000-0003-3971-0336)
- Assaf Arie Barg (ORCID: https://orcid.org/0000-0002-8329-8409)
- Omri Cohen (ORCID: https://orcid.org/0000-0002-8328-9748)
- Dan Geller
- Gili Kenet
- Tlalit Barhod
Institutions
- University of Iowa (US)
- Tel Aviv University (IL)
- Sheba Medical Center (IL)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2024-11-24
- DOI
- https://doi.org/10.1002/pbc.31456
- Citations
- 2
- Primary Topic
- Hemophilia Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.91